Integral cross section measurements of a few threshold reactions induced by Am/Be neutrons

Uddin, M.S.; Qaim, S.M.; Spahn, Ingo; Rumman-Uz-Zaman,; Hossain, Syed Mohammad; Rakib-Uz-Zaman,

doi:10.1515/ract-2014-2308

Cited by 6 publications

(2 citation statements)

References 9 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…[26] and that for the 67 Zn(n,p) 67 Cu reaction from Ref. [25], in both cases using a nat Zn target.…”

Section: Novel Therapeutic Radionuclidesmentioning

confidence: 93%

“…In the case of 67 Cu, for example, out of the four promising production reactions, namely 67 Zn(n,p) 67 Cu, 68 Zn(γ ,p) 67 Cu, 70 Zn(p,α) 67 Cu and 68 Zn(p,2p) 67 Cu, the fission spectrum averaged (n,p) cross section is known [cf. 24,25] but it shows some discrepancy with the value integrated from the excitation function. In the case of the (γ ,p) reaction, only the integral yield has been measured [26].…”

Section: Novel Therapeutic Radionuclidesmentioning

confidence: 95%

See 1 more Smart Citation

Nuclear data for medical applications: An overview of present status and future needs

Syed

2017

EPJ Web Conf.

View full text Add to dashboard Cite

Abstract.A brief overview of nuclear data required for medical applications is given. The major emphasis is on radionuclides for internal applications, both for diagnosis and therapy. The status of the presently available data is discussed and some of the emerging needs are outlined. Most of the needs are associated with the development of non-standard positron emitters and novel therapeutic radionuclides. Some new developments in application of radionuclides, e.g. theranostic approach, multimode imaging, radionanoparticles, etc. are described and the related nuclear data needs are discussed. The possible use of newer irradiation technologies for medical radionuclide production, e.g. intermediate energy charged-particle accelerators, high-power electron accelerators for photon production, and spallation neutron sources, will place heavy demands on nuclear data.

show abstract

“…[26] and that for the 67 Zn(n,p) 67 Cu reaction from Ref. [25], in both cases using a nat Zn target.…”

Section: Novel Therapeutic Radionuclidesmentioning

confidence: 93%

Section: Novel Therapeutic Radionuclidesmentioning

confidence: 95%